Hyperphagia Clinical Trial
The goal of this project is to identify brain mechanisms by which Noninvasive brain stimulation (NIBS) could decrease hyperphagia. The investigators will synchronously deliver NIBS and measure brain activity in a randomized, crossover, sham-controlled, fully blind study. This work will reveal brain mechanisms to reduce hyperphagia and may contribute to new therapeutic avenues to treat this eating disorder.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02629991 -
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
|
Phase 2 | |
| Recruiting |
NCT05939453 -
Impact of Bright Light Therapy on Prader-Willi Syndrome
|
N/A | |
| Terminated |
NCT03790865 -
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
|
Phase 2/Phase 3 | |
| Completed |
NCT03375853 -
Computerized Response Training Obesity Treatment
|
N/A | |
| Completed |
NCT04150991 -
Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome
|
N/A | |
| Recruiting |
NCT06239064 -
Early Genetic Identification of Obesity
|
||
| Recruiting |
NCT05044000 -
Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome
|
N/A | |
| Terminated |
NCT00175305 -
Prader-Willi Syndrome and Appetite
|
Phase 3 | |
| Recruiting |
NCT05200182 -
fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating
|
N/A | |
| Completed |
NCT01863017 -
Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome
|
N/A | |
| Recruiting |
NCT03197662 -
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
|
Phase 2 |